Article Details
Retrieved on: 2021-05-20 14:02:07
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
According to Truist Securities, the prior rating for Allogene Therapeutics Inc (NASDAQ:ALLO) was changed from Hold to Buy. Allogene Therapeutics ...
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here